VANCOUVER, Aug. 14, 2019 /CNW/ - Harvest One Cannabis
Inc. ("Harvest One" or the "Company")(TSX-V: HVT;
OTCQX: HRVOF) is pleased to announce that the Company's
wholly-owned subsidiary, United Greeneries Ltd. ("United
Greeneries"), has completed Phase I of a pilot program (the "Pilot
Program") in conjunction with Shoppers Drug Mart ("Shoppers")
and TruTrace Technologies Inc. ("TruTrace")(CSE: TTT; OTCQB: TTTSF)
designed to increase the transparency and validation of products
within the medical cannabis industry.
The Pilot Program uses the StrainSecure™ technology as a master
registry for standardized testing, product verification, and
quality assurance. Under StrainSecure™, plant testing data and
genomic verification for each plant batch is utilized for
intellectual property protection and strain validation.
As recently announced by Shoppers, Phase 1 of the Pilot Program
has been completed and United Greeneries successfully met all of
the requirements of Phase 1 due in part to their early adoption of
TruTrace's StrainSecure™ platform and implementation of the Master
Genome Strain and Clone Registration Program. Phase 2 is expected
to run until late November, followed by full production and
implementation.
"Now that we have completed Phase 1 of the Pilot Project,
medically-registered patients can have an increased level of
confidence in the consumption of our Satipharm branded cannabis
through Shoppers" said Grant Froese,
CEO of Harvest One. "We are delighted to be a part of this
groundbreaking effort that is leading the way towards transparency
and traceability within the medical cannabis industry."
"Harvest One has been a strong supporter of our mission and an
early adopter of our technology for quite some time," said
Robert Galarza, CEO of TruTrace
Technologies. "Their entire team views the medical cannabis
industry with a great deal of sophistication and foresight;
TruTrace is very excited to be working with Harvest One on this
program."
In February 2019, Harvest One
joined TruTrace's Master Genome Strain and Clone Registration
Program. In the following months, DNA was collected from
United Greeneries cannabis strains and registered with
StrainSecure™. Following the registration of its strains, an
initial set of Harvest One products were provisioned to carry
TruTrace's Seal of Authenticity. This process provides an
independent means for Harvest One to guarantee the origin of its
products, thereby offering its consumers increased transparency and
quality assurance.
Through its early participation in the StrainSecure™ system,
Harvest One was ideally positioned for the Shoppers Pilot Program,
which is founded on the same technology. Harvest One is evaluating
further opportunities to exploit the detailed, genetic-level
knowledge of its various strains.
About Harvest One Cannabis Inc.
Harvest One is a global consumer packaged goods company that
develops and distributes premium health, wellness, and lifestyle
products to patients and consumers in regulated markets around the
world. The Company's portfolio of premium products is designed to
enhance the quality of life. Shareholders have significant exposure
to the entire cannabis value chain through four wholly-owned
subsidiaries: United Greeneries, a Licensed Producer; Satipharm
(medical and nutraceutical); Dream Water Global and Delivra
(consumer products with an emphasis on sleep, pain, and anxiety),
and a minority interest in Burb Cannabis (retail operations). For
more information, please visit www.harvestone.com
About TruTrace Technologies
TruTrace Technologies has developed the first integrated
blockchain platform to register and track intellectual property in
the cannabis industry. TruTrace's technology allows cannabis
growers and breeders to identify and secure rights to their
intellectual property. It also streamlines the administrative
process and reduces the costs of genetic and mandatory
quality-control testing for legal cannabis. TruTrace's technology
is proprietary, immutable and cryptographically secure, thereby
establishing an accurate and permanent account for cannabis strains
from ownership to market.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release constitute
forward-looking information. These statements relate to future
events or future performance. The use of any of the words "could",
"intend", "expect", "believe", "will", "projected", "estimated" and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking
information and are based on the Company's current belief or
assumptions as to the outcome and timing of such future events.
Actual future results may differ materially. The forward-looking
information contained in this press release is made as of the date
hereof, and the Company is not obligated to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Because of the risks, uncertainties and
assumptions contained herein, investors should not place undue
reliance on forward-looking information. The foregoing statements
expressly qualify any forward-looking information contained
herein.
Neither TSX-V nor its Regulation Services Provider (as that
term is defined in the policies of the TSX-V) accept responsibility
for the adequacy or accuracy of this release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/harvest-one-announces-completion-of-phase-i-of-the-shoppers-drug-mart--trutrace-technologies-pilot-program-for-validation-of-medical-cannabis-300901628.html
SOURCE Harvest One Cannabis Inc.